Boston Scientific Securities Litigation
This settlement is closed to new claims. You can still see what it was about and follow the case in court below. Looking for money you can still claim? Browse open settlements →
What happened
Boston Scientific Corporation and certain executives allegedly made false and misleading statements regarding the company's Lotus Edge medical device in violation of federal securities laws. Investors who purchased Boston Scientific stock during the class period allege they were damaged by these misstatements.
Do you qualify?
Anyone who purchased or otherwise acquired Boston Scientific common stock between September 16, 2020 and November 16, 2020, inclusive, and were damaged as a result. Excluded are defendants, their family members, company officers and directors, parent/subsidiary companies, and those who requested exclusion.
How to file
The claims administration was completed as of February 7, 2025. Distributions have already been made to eligible claimants with subsequent distributions on a rolling basis. For more information, contact the Claims Administrator at 877-595-0084 or info@BostonScientificSecuritiesLitigation.com.
Common questions
- How much does the Boston Scientific Securities Litigation pay?
- The total settlement fund is $38.5M. Actual amounts depend on how many valid claims are filed — most settlements divide a fixed fund pro rata, so a higher claim rate means a smaller individual check. An "up to" figure is a cap, not a guarantee.
- Is the Boston Scientific Securities Litigation notice real, or a scam?
- JND Legal Administration is the settlement administrator for this case. Claims are filed at bostonscientificsecuritieslitigation.com. Filing a class action claim is always free — no legitimate settlement charges you to claim, and no administrator will ask for payment, a gift card, or your full Social Security number by email or text. If a notice asks for any of those, it is not from the administrator. When in doubt, ignore the link you were sent and go to the official settlement website directly.
- When will payments from the Boston Scientific Securities Litigation be sent?
- Class action payouts typically take 12 to 24 months after the claim deadline, and longer if the settlement is appealed. The final approval hearing for this case is set for April 23, 2024; no payments can be issued before a settlement receives final approval.
New to class actions?
This summary was generated from public settlement documents and may contain errors. Confirm eligibility, deadlines, and payment terms on the official settlement website before filing. ClaimWatch is not a law firm and this is not legal advice. Filing a claim is free.
More securities settlements
View all →Revance Securities Settlement
Revance Therapeutics and its executives made material misrepresentations and omissions regarding the company's relationship with Teoxane SA and the tender offer and merger transaction with Crown Laboratories, Inc., allegedly violating federal securities laws. Defendants deny any wrongdoing or liability.
Not yet determinable; depends on number of valid claims submitted
Biogen Securities Litigation Settlement
Biogen Inc. investors have settled a securities litigation case for $18.9 million in cash. The settlement resolves claims related to purchases of Biogen common stock during the specified class period.
NJ Bureau of Securities Settlement with Credit Suisse
Credit Suisse allegedly violated New Jersey Securities Law by making materially false and misleading statements regarding RMBS trust certificates and engaging in fraudulent practices. On October 24, 2022, the court entered a consent order requiring Credit Suisse to pay $300 million in restitution to investors. Credit Suisse neither admitted nor denied the allegations.
Stitch Fix Securities Litigation Settlement
Stitch Fix, Inc. is settling a securities class action lawsuit without admitting wrongdoing. The Lead Plaintiffs alleged that Stitch Fix issued misleading statements about its business, and shareholders who purchased the stock during the class period suffered damages as a result.